Help
Subscribe


All of GastroHep is now free access! - Click here to register Read For FREE - Our full range of review articles
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Guido Tytgat Profile of Pete Peterson Profile of Peter Cotton Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Predicted effects of HCV treatment vary among European countries

The most recent issue of Gastroenterology investigates the predicted effects of treatment for HCV infection among European countries.

News image

The dynamics of hepatitis C virus (HCV) infection, as well as screening practices and access to therapy, vary among European countries.

Dr Philippe Mathurin and colleagues from France determined the magnitude of the effects of such differences on incidence and mortality of infection.

The researchers compared the dynamics of infection and screening and treatment practices among Belgium, France, Germany, Italy, Spain, and the United Kingdom.

The team also assessed the effects of treatment with pegylated interferon and additional effects of triple therapy with protease inhibitors.

Antiviral treatment of patients with HCV genotype 1 will reduce mortality by 10% overall
Gastroenterology

The research team created a country-specific Markov model of HCV progression based on published epidemiologic data, and reports of competitive and hepatocellular carcinoma mortality for the 6 countries.

The model was used to predict the incidence of HCV-related cirrhosis and its mortality until 2021 for each country.

From 2002 to 2011, antiviral therapy reduced the cumulative incidence of cirrhosis by 7% and deaths by 3% overall.

The team observed that reductions in incidence and mortality values ranged from 4% and 2%, respectively, in Italy to 16% and 9%, respectively, in France.

From 2012 to 2021, antiviral treatment of patients with HCV genotype 1 infection that includes protease inhibitor–based triple therapy will reduce the cumulative incidence of cirrhosis by 18%, and mortality by 10% overall.

The team found that the smallest reduction is predicted for Italy, and the highest is for France.

Dr Mathurin's team commented, "Although HCV infection is treated with the same therapies in different countries, the effects of the therapies on morbidity and mortality vary significantly."

"In addition to common guidelines that are based on virologic response-guided therapy, there is a need for public health policies based on population-guided therapy."

Gastroenterology 2012: 143(4): 974-985.e14
09 October 2012

Go to top of page Email this page Email this page to a colleague

 22 July 2014

Advanced search
 22 July 2014 
Thromboembolism in IBD
 22 July 2014 
Cognitive behavioral therapy in IBS
 22 July 2014 
Alcohol and colorectal adenoma risk
 21 July 2014 
Stents to prevent post-ERCP pancreatitis
 21 July 2014 
Psychometric validation of IBS symptom severity
 21 July 2014 
Mortality in IBD
 18 July 2014 
Treatment of enteropancreatic neuroendocrine tumors
 18 July 2014 
Ulcer complications and dyspeptic symptoms
 18 July 2014 
ERCP with overtube-assisted enteroscopy
 17 July 2014 
Treatment of H. pylori
 17 July 2014 
Ultrasound for diagnosis of gastric varices
 17 July 2014 
Small intestinal permeability in diarrhea predominant IBS
 16 July 2014 
Mortality after colectomy in IBD
 16 July 2014 
Esophageal cancer missed at endoscopy
 16 July 2014 
Screening for Hepatitis B
 15 July 2014 
Diagnosing diverticulitis
 15 July 2014 
Variation in management decisions for colorectal cancer
 15 July 2014 
Muscle cramps in cirrhosis
 14 July 2014 
Predicting the course of ulcerative colitis
 14 July 2014 
Choice in colorectal cancer screening tests
 14 July 2014 
Adhesions in abdominal surgery
 11 July 2014 
Temporal evolution of antidrug antibodies in IBD
 11 July 2014 
Atopy and functional gastrointestinal disorders
 11 July 2014 
Fecal microbiota transplant for C. diff
 10 July 2014 
Acid-suppressive medications and cancer risk in Barrett's
 10 July 2014 
Personalized medicine in the management of IBD
 10 July 2014 
Pregnancy outcome in anti-TNF treated women with IBD
 09 July 2014 
Quality of care provided to patients with varices
 09 July 2014 
Eosinophilic esophagitis and celiac disease
 09 July 2014 
Diagnosis and management of adult celiac disease
 08 July 2014 
NSAID-induced small intestinal injury
 08 July 2014 
Drug-induced liver injury
 08 July 2014 
Screening for Hep B
 07 July 2014 
Obesity and complications after lapaproscopic colorectal surgery
 07 July 2014 
Everolimus and advanced hepatocellular carcinoma
 07 July 2014 
Pediatric celiac disease risk factors
 04 July 2014 
Day-case vs inpatient laparoscopic fundoplication
 04 July 2014 
Alcohol assessment in liver transplant
 04 July 2014 
Clinical competence in colorectal cancer surgery
 03 July 2014 
Predicting acute liver failure in drug-induced liver injury
 03 July 2014 
Cognitive dysfunction impairs quality of life after liver transplant
 03 July 2014 
NOTES for colon resections
 02 July 2014 
Routine colonoscopy for uncomplicated diverticulitis
 02 July 2014 
Risk of stroke in ulcerative colitis
 02 July 2014 
Hemodialysis during liver transplant
 01 July 2014 
Outcomes for pregnant women with primary biliary cirrhosis
 01 July 2014 
Liver-prognosis assessment in Hep C
 01 July 2014 
Mortality from biliary diseases requiring ERCP
 30 June 2014 
Combination therapy for eradication of Helicobacter pylori
 30 June 2014 
Drug-induced liver injury
 30 June 2014 
Surrogate for adenoma detection rate
 27 June 2014 
Infliximab and luminal pediatric Crohn's
 27 June 2014 
Colonoscopy surveillance intervals
 27 June 2014 
Endoscopy protocol for serrated polyposis syndrome
 26 June 2014 
Cognitive impairment in celiac disease
 26 June 2014 

Congenital malformations in offspring of parents with celiac disease

 26 June 2014 
Risk of colorectal adenomas and glucose metabolism
 25 June 2014 
Acceptance of split-dose bowel prepartation for colonoscopy
 25 June 2014 
Preventing gallbladder stones during weight loss
 25 June 2014 
Evaluating disease activity in small bowel Crohn's

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2014 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us